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BLINDED TITLE PAGE 
Automated quantitative CT versus visual CT scoring in idiopathic 
pulmonary fibrosis: validation against pulmonary function  
 
PURPOSE: To determine whether a novel CT post-processing software technique (CALIPER) is superior 
to visual CT scoring as judged by functional correlations in idiopathic pulmonary fibrosis.  
 
MATERIALS and METHODS: 283 consecutive patients with idiopathic pulmonary fibrosis had CT 
parenchymal patterns evaluated quantitatively with CALIPER and by visual scoring. These two 
techniques were evaluated against: FEV1, FVC, DLco, Kco and a composite physiological index (CPI), 
with regard to extent of interstitial lung disease, extent of emphysema and pulmonary vascular 
abnormalities. 
 
RESULTS: CALIPER-derived estimates of interstitial lung disease extent demonstrated stronger 
univariate correlations than visual scores for most pulmonary function tests: (FEV1: CALIPER R2=0·29, 
visual R2=0·18, FVC: CALIPER R2=0·41, visual R2=0·27; DLco: CALIPER R2=0·31, visual R2=0·35; CPI: 
CALIPER R2=0·48, visual R2=0·44). Correlations between CT measures of emphysema extent and 
pulmonary function tests were weak and did not differ significantly between CALIPER and visual 
scoring. Intriguingly, the pulmonary vessel volume provided similar correlations to total interstitial 
lung disease extent scored by CALIPER for FVC, DLco and CPI (FVC: R2=0·45; DLco: R2=0·34; CPI: 
R2=0·53).  
 
CONCLUSIONS: CALIPER was superior to visual scoring as validated by functional correlations with 
pulmonary function tests. The pulmonary vessel volume, a novel CALIPER CT parameter with no visual 
scoring equivalent, has the potential to be a CT feature in the assessment of patients with idiopathic 
pulmonary fibrosis and requires further exploration.  
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INTRODUCTION 
Computer-based quantitative CT evaluation has the potential for greater precision than visual scoring 
in the estimation of the extent of diffuse parenchymal diseases. A new generation of computer-based 
CT software tools have demonstrated similar results between computer quantitation and visual 
quantitative scoring in small-scale studies in patients with idiopathic pulmonary fibrosis (IPF), 1, 2 with 
distinct improvement in performance on older, less sophisticated software programs.3, 4  
 
Pulmonary damage in IPF is the consequence of pathological involvement of three components of the 
lung: the parenchyma, the vasculature (largely due to pulmonary hypertension)5 and, in a large 
proportion of IPF patients who are cigarette smokers, co-existent emphysema.6, 7 Our study assessed 
baseline involvement of these three compartments using traditional visual CT evaluation and a 
sophisticated quantitative CT software tool, CALIPER (Computer-Aided Lung Informatics for Pathology 
Evaluation and Rating), developed at the (_____________). In our study, we set out to validate 
computer-based CT scoring by examining correlations between CT patterns against pulmonary 
function tests.  
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MATERIALS and METHODS  
Study population and clinical information: 
A retrospective analysis of an interstitial lung disease database identified all new consecutive 
patients, (over a four and a half year period (January 2007 to July 2011)), with a multidisciplinary 
team diagnosis of IPF according to published guidelines.8 Patients with a non-contrast, supine, 
volumetric thin section CT were collected, and subsequent exclusions are shown (as per CONSORT in 
Figure 1). Pulmonary function and echocardiography protocols are explained in the online appendix. 
The DICOM images for the CT scans were transferred to the (________________________________) 
for blinded CALIPER processing. Approval for this study of clinically indicated CT and pulmonary 
function data was obtained from the Institutional Ethics Committee of the (____________) and the 
Institutional Review Board of (____________).  
 
CT protocol: 
The CT scans were obtained using a 64-slice multiple detector CT scanner (Somatom Sensation 64, 
Siemens, Erlangen, Germany) or a 4-slice multiple detector CT scanner (Siemens Volume Zoom, 
Siemens, Erlangen, Germany. To satisfy requirements for processing by the CALIPER algorithm, all 
scans were reconstructed using a high spatial frequency, B70 kernel (Siemens, Munich, Germany). All 
patients were scanned from lung apices to bases, at full inspiration, using a peak voltage of 120kVp 
with tube current modulation (range 30-140 mA). Images of 1mm thickness were viewed at window 
settings optimized for the assessment of the lung parenchyma (width 1500 H.U.; level -500 H.U.). 
 
CT visual evaluation: 
Each CT scan was evaluated independently by two radiologists (___,___) with 5 and 7 years thoracic 
imaging experience respectively, blinded to all clinical information. An initial training dataset of 15 
non-study cases was used to help to identify pre-existing biases. The scores of the test cases were 
reviewed and the most widely discrepant results discussed with a third radiologist (__).  
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CTs were scored on a lobar basis using a continuous scale. The total interstitial lung disease (ILD) 
extent was estimated to the nearest 5%, and sub-classified into four patterns: reticular pattern, 
ground glass opacification, honeycombing and consolidation, using definitions from the Fleischner 
Society glossary of terms for thoracic imaging.9 To derive a lobar percentage for each parenchymal 
pattern, the total lobar ILD extent was multiplied by individual lobar parenchymal pattern extents and 
divided by 100. The percentage (to the nearest 5%) of each lobe that contained mosaicism (decreased 
attenuation component) or emphysema was recorded. The individual lobar percentages of each 
parenchymal pattern were summed for each radiologist and divided by six to create an averaged 
lobar score per pattern, per scorer per case.  
 
Traction bronchiectasis, as defined in the Fleischner society glossary of terms, 9 was assigned with a 
categorical “severity” score that took into account the average degree of airway dilatation within 
areas of fibrosis as well as the extent of dilatation throughout the lobe and was given an overall score 
of: none=0, mild=1, moderate=2, severe=3. An index of pulmonary hypertension (main pulmonary 
artery:ascending aorta ratio) was assessed by a single scorer using electronic caliper diameter 
measurements of the ascending aorta and pulmonary artery diameters at the level of the pulmonary 
artery bifurcation.10 
 
The identification of systematic biases in visual scores was achieved by plotting the spread of 
differences in parenchymal pattern scores between observers. The most disparate 5% (two standard 
deviations) of values were arbitrated by a third scorer for all parameters except traction 
bronchiectasis, thereby minimizing bias within the original scorers. The original scorers derived a 
consensus for the traction bronchiectasis score. If a single parenchymal subtype extent was changed 
at consensus, the other parameters were modified, following CT review, to retain an overall sum of 
100% for the four parenchymal subtypes. Similarly, if the lobar percentages of total interstitial 
disease, emphysema or mosaicism varied, the other two parameter extents were rescored. 
 
CALIPER CT evaluation: 
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Data processing: Initial data processing steps involved extraction of the lung from the surrounding 
thoracic structures and segmentation into upper, middle and lower zones. Lung segmentation was 
performed with an adaptive density-based morphological approach,11 whilst airway segmentation 
involved iterative three-dimensional region growing, density thresholding (thresholds including -
950HU and -960HU) and connected components analysis.  
 
Parenchymal tissue type classification was applied to 15x15x15 voxel volume units using texture 
analysis, computer vision-based image understanding of volumetric histogram signature mapping 
features and 3D morphology.12 The CALIPER tool was trained by sub-specialty thoracic radiologist 
consensus assessment of pathologically confirmed datasets.2, 12 
 
Pattern evaluation: CALIPER and visual CT were used to quantify pulmonary variables in three 
domains: 
i) total extent of interstitial disease 
ii) total extent of emphysema  
iii) pulmonary vessels 
 
CALIPER evaluation of CT data involved algorithmic identification and volumetric quantification of 
every voxel volume unit into one of eight radiological parenchymal features: normal lung, three 
grades of decreased lung attenuation (grade 1=mild, 2=moderate 3=marked), ground glass 
opacification, reticular pattern, honeycombing and the pulmonary vessels (Figure 2). Volumes for all 
eight parenchymal features were converted into a percentage using the total lung volume also 
measured by CALIPER.  
 
The final CALIPER emphysema index was defined by pre-processing the CALIPER variables against PFTs 
and visual comparison of CT scans. Using univariate linear correlations, Grade 1 decreased 
attenuation (DA) demonstrated no fit against the visual emphysema extent score or against Kco and 
was therefore not included within the CALIPER emphysema score. On inspection of colour maps, 
Grade 1 DA was shown to encompass areas of patchy centrilobular emphysema and considerable 
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amounts of normal lung (Figure 2a-c), which accounted for its large extent and lack of functional 
impact (Table 1). The sum of Grade 2 and 3 DA was taken to represent CALIPER emphysema and the 
suitability of the new variable was confirmed on analysis of individual colour maps (Figure 2a-c) that 
demonstrated that Grade 2 and 3-DA corresponded to discrete and conglomerate foci of emphysema. 
 
Segmentation of pulmonary vessels, prior to their extraction, was achieved using an optimized multi-
scale tubular structure enhancement filter based on the eigenvalues of the Hessian matrix. The filters 
calculated the 2nd-order derivatives that occurred in the regions that surrounded each pulmonary 
voxel. The eigenvalues of the Hessian matrix that were constructed from the derivatives were then 
analyzed, and from these values, it was possible to determine the likelihood that an underlying voxel 
was connected to a dense tubular structure and therefore represented a vessel.12, 13 The pulmonary 
vessel volume (PVV) score quantified the volumes of pulmonary arteries and veins excluding vessels 
at the lung hilum as a percentage of lung volume (Figure 3). Total ILD extent represented the sum of 
ground glass, reticular and honeycomb percentages.  
 
Statistical analysis: 
Data are given as means with standard deviations, or numbers of patients with percentages where 
appropriate. Interobserver variation for visual scores was assessed using the single determination 
standard deviation.  
 
Correlations between the extents of parenchymal patterns and individual PFTs were examined using 
Pearson’s product moment correlation. Univariate and multivariate analyses were undertaken to 
investigate relationships between CALIPER or visual CT evaluation and pulmonary function tests. In 
multivariate analyses, robustness of relationships were tested by bootstrapping the dataset with 1000 
samples. In all study analyses, a p-value of <0.01 was considered significant. Models were formally 
tested for heteroscedasticity to confirm that the assumptions of parametric analysis had been 
satisfied. Statistical analyses were performed with STATA (version 12, StatCorp, College Station, TX, 
USA).  
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RESULTS: 
Baseline data 
The final study group comprised 283 consecutive patients with a multidisciplinary diagnosis of IPF. 
Age, gender, mean visual scores, CALIPER scores and pulmonary function tests are shown in Table 1. 
Discordances between CALIPER and visual estimations of total ILD extent, emphysema and the 
various individual parenchymal patterns are shown in Table 1 and an illustrative example is shown in 
Figure 2. Visual scores identified on average 1.6 times more ILD than CALIPER and 10 times more 
honeycombing than CALIPER. Interobserver variation values for the visual scores are provided in Table 
2. 
 
Univariate relationships 
The relationships between pulmonary function parameters (FEV1, FVC, DLco, Kco, CPI) and CT 
variables are shown in Table 3. Taken across the PFTs, CALIPER ILD extent was either superior to 
(FEV1, FVC) or comparable with (DLco, CPI) visual scoring (Table 3). CALIPER ILD extent and PVV had 
very similar correlations with pulmonary function indices. The PVV correlations were either superior 
to (FEV1, FVC, CPI) or comparable with (DLco) visual ILD extent scores. PVV increased with ILD extent 
(Quadratic R2=0.76), but less so with more advanced disease. The visual pulmonary artery:aorta 
diameter ratio demonstrated no relationship to any functional index. 
 
Multiple regression 
Multivariate regression analyses of visual and CALIPER scores of pulmonary vasculature, total 
interstitial disease extent and emphysema extent were analysed against pulmonary function tests 
(Table 4). PVV and ILD extent could not be included in the same model due to major co-linearity and 
so were examined in separate models (Model 1 containing CALIPER ILD and Model 2 containing PVV). 
 
In Model 1, CALIPER ILD extent was clearly superior for two PFTs (FEV1, FVC), (confirmed on 
bootstrapping the dataset with 1000 samples), with visual ILD extent discarded. CALIPER and visual 
ILD extents were complementary for two PFTs (DLco, CPI) with both variables retained (again 
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confirmed on bootstrapping the dataset with 1000 samples). In the second model, CALIPER PVV was 
the strongest determinant of all examined PFTs. Although visual ILD extent was retained for DLco and 
CPI, there was minimal effect on model fit when it was discarded (DLco change: R2 0.04; CPI change R2 
0.03). Similarly, the inclusion of individual CT patterns (e.g. ground glass opacity, reticular pattern and 
honeycombing), whether quantified by CALIPER or visually, resulted in only a minimal improvement in 
correlations with PFTs (R2 values increasing by <0.02).  
 
Given the overall strong correlations between PVV and the various pulmonary function tests, 
relationships between PVV and RVSP were explored. Univariate analysis of a subgroup of 150 patients 
with concurrent right ventricular systolic pressure (RVSP) measured on echocardiography was 
performed. RVSP was found to explain 20% of the variability of the PVV (R2=0·20, P<0·0001). In the 
same 150 patients, the extent of ILD measured by both CALIPER (R2=0·73, P<0·0001) and visually 
(R2=0·47, P<0·0001), better explained PVV variability. Furthermore, with these two CT variables 
included in separate models, RVSP had no independent linkage with PVV. 
 
Post-hoc evaluation: CALIPER-based validation of CPI 
On the basis of the strong linkages between CALIPER ILD extent and PFTs, the robustness of the CPI 
was validated using CALIPER-scored ILD extent in the current study group. This showed that the same 
three best-fit PFTs, as used in the original CPI model, predicted CALIPER ILD extent: 
 
CALIPER-derived CPI = 66.0 – (0.47 x DLco) – (0.67 x FVC) + (0.32 x FEV1) 
 
Correlation of the new CPI against the old CPI score demonstrated a strong linkage as shown in the 
graph in Figure 4 (R2=0.95). 
 
  
 10 
DISCUSSION 
Our study has shown that in an IPF population, CALIPER derived interstitial and vascular parameters 
correlated more strongly with pulmonary function indices (FEV1, FVC) or were at least comparable to 
visual scores (DLco, CPI). Consequently, it was felt logical to explore the robustness of the CPI using an 
objective scoring methodology (CALIPER) and, in so doing, the CPI was vindicated. Importantly, we 
have also shown that the pulmonary vessel volume, a novel CALIPER-derived percentage of the lung 
composed of pulmonary arteries and veins, is surprisingly strongly linked to the extent of interstitial 
disease.  
 
The increase in the size and number of drug trials in IPF has necessitated the development of new 
automated computer-based algorithms capable of analysing hundreds of CTs per study. The accuracy 
of the new computer-based techniques requires validation to ensure that they are at least 
comparable to visual CT scoring. One of the steps in validating the accuracy of CT in assessing disease 
extent is by examining the relationship between CT estimates, however obtained, and pulmonary 
function measures of disease severity. There are numerous structure-function studies in interstitial 
lung disease, but these have almost exclusively relied on visual scoring of total and individual pattern 
extents, with all the inherent problems of interobserver agreement.14-16 
 
In our study, CALIPER-derived interstitial and vascular markers clearly demonstrated stronger or 
comparable correlations with all cardinal pulmonary function tests than visual scores. The strong 
univariate correlations between both visual and CALIPER-scored total ILD extent and pulmonary 
function parameters are in line with previous IPF studies. 16, 17 Whilst the primary purpose of this 
study was a validation exercise of CALIPER against visual scores, the strong correlations between 
CALIPER scores and PFTs made it possible to examine historical derivation of the CPI. The CPI, 
originally derived using a subjective visual scoring system, was validated as a robust variable following 
replication of the CPI by using scores from the objective CALIPER system. 
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CALIPER was less sensitive to the extent of emphysema as compared to visual scoring and less 
accurate as judged by correlations with pulmonary function indices. Nevertheless, the positive 
correlations between visually and CALIPER scored emphysema and FVC, identified in the current 
study, are consistent with previous studies in IPF patients with co-existent emphysema. 18, 19 
 
On multivariate analysis of CALIPER and visual variables, it was striking that the strongest 
independent parameter predictive of pulmonary function tests was the PVV. We had assumed a priori 
that PVV was a measure of pulmonary vessel involvement, but intriguingly our investigations revealed 
that PVV was not only a ILD marker per se, but that it was co-linear with both CALIPER and visual ILD 
extents. PVV was at least as strong as CALIPER ILD extent in its linkage with key PFTs (FVC, CPI). 
Furthermore, after correcting for the extent of ILD, no linkage between PVV and RVSP remained, 
thereby establishing that PVV was not an index of pulmonary hypertension.  
 
Discordances between CALIPER and visual scores of total ILD extent and honeycombing were assessed 
by analyzing outlying cases and were found to relate largely to differences in scoring methodologies. 
On visual evaluation, each lobe represented a sixth of the total lung volume, regardless of the extent 
of lobar disease. CALIPER however, assessed parenchymal patterns, as a proportion of the total lung 
volume. Lower lobes, contracted by the retractile fibrosis of UIP, contribute a smaller percentage of 
disease than, for example, non-fibrotic upper lobes and were thus under-represented by CALIPER 
when compared to visual scores. The disparity in visual and CALIPER estimates of reticular pattern 
and ground glass opacity reflect differences in categorization of a pattern of intermixed fine 
reticulation and ground glass opacity (Figure 2d-f). Furthermore, review of individual cases showed 
that quite frequently, CALIPER characterized visually scored honeycombing as reticular pattern and 
ground glass opacity (Figure 2g-i). 
 
Our findings suggest that a computer-based quantitative CT tool such as CALIPER, has several valuable 
roles for the evaluation of patients with IPF. The improved sensitivity of CALIPER in evaluating ILD 
extent, when compared to visual scoring, has the potential to enhance understanding of the natural 
history of IPF by improving the accuracy of identifying serial change. In the sphere of drug trials, 
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computer-based CT evaluation has several possible applications. CALIPER could be used to correct for 
baseline CT disease extent in patients at the start of a trial and it could also be applied as a monitoring 
tool in the context of end-points. In the current study, recalibration of CALIPER software was required 
to analyse the Siemens B70f algorithms performed in our department, with the result that post-
recalibration, similar results for parenchymal pattern extents were achieved when CALIPER analysed 
both edge-enhancing algorithms such as a Siemens B70f and “less edge-enhancing” algorithms such 
as a Siemens B46f, (the algorithm constituting most of CALIPER’s original training dataset). A 
consequence of CALIPERs recalibration was an improvement in its versatility, which has relevance for 
multicentre drug trials, where CTs in different centres can be reconstructed with a range of different 
algorithms. 
 
CALIPER could also make a useful contribution to the investigation of combined fibrosis and 
emphysema (CPFE). The strong correlations with functional indices we have demonstrated suggest 
that CALIPER would be a more suitable tool than visual scores to quantify ILD extent in CPFE, although 
conversely visual scoring may be best placed to quantify emphysema extent. Both methodologies 
used together may better delineate the contribution of each component of CPFE.  
 
With regard to PVV, individual colour overlay maps demonstrated some contamination of the variable 
by areas of reticulation (Figure 3), particularly in cases with extensive pulmonary fibrosis. 
Nonetheless, the variable primarily reflects the quantitation, by CALIPER, of large and small vessels in 
the lung, in a way that has not, to date, been possible by human scorers. Evaluating this new 
parameter has resulted in a credible additional CT measure to visual ILD extent scores when 
quantifying interstitial involvement in IPF. A possible explanation for the relationship between PVV 
and ILD extent relates to the increased negative intra-thoracic pressure that non-compliant fibrotic 
lungs generate during inspiration. The transmission of high negative pressures into the lung 
parenchyma could in turn affect compliant vessels, resulting in vascular dilatation throughout the 
lung and an increase in capacitance. However deciphering the exact pathophysiological mechanisms 
that link interstitial damage to vascular volume requires further investigation. Furthermore, the 
potential prognostic role of PVV in patients with fibrosing lung disease is worthy of exploration. 
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Some limitations to the CALIPER technique are evident. One lies in the poor correlations we have 
identified between CALIPER emphysema extent and functional indices, (in particular Kco). Improving 
the detection of non-conglomerate emphysema by CALIPER would be a preliminary yet feasible 
objective. The complexities in scoring CT parenchymal pattern extents, be that visual or computer-
based, in a disease that is inevitably associated with volume loss are considerable. Whilst 
discrepancies between CALIPER and visual scores for parenchymal patterns such as honeycombing 
have been partly explained, further studies directed towards clarifying the reasons behind the 
differences in disease extent scores are needed. Lastly, the minor contamination of the PVV signal by 
reticulation in cases with severe fibrosis, might be considered a limitation, as it could be thought to 
dilute the relationships between PVV and functional indices. However improvement and greater 
sophistication of the algorithm to detect vessels (versus reticulation) may result in simply 
strengthening the correlations we have already shown. 
 
In conclusion, we have shown that CALIPER measures of lung disease are more strongly related to 
pulmonary function tests than visual scores. Strong links between CALIPER estimation of pulmonary 
vessel volume and pulmonary function tests suggests that evaluation of pulmonary vessel volume 
may be an important new index when assessing disease severity in patients with IPF. 
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FIGURE CAPTIONS 
Figure 1. CONSORT diagram illustrating the selection of patients for the final study population. ILD = 
interstitial lung disease, CTD = connective tissue disease, IPF = idiopathic pulmonary fibrosis, LCH = 
Langerhans cell histiocytosis, LAM = Lymphangioleiomyomatosis, CT = computed tomography. 
 
Figure 2A-C. Axial CT slices, axial CALIPER-derived colour image overlays and three-dimensional 
CALIPER coronal rendering of the lungs displaying parenchymal patterns as various colours (Dark 
green=normal lung, light green=grade 2 decreased attenuation area, light blue=grade 2 decreased 
attenuation area, dark blue=grade 3 decreased attenuation area, yellow=ground glass opacity, 
orange=reticular pattern, brown=honeycombing).  
2A(i-iii) 75-year-old male ex-smoker with a 40-pack year smoking history. Mean visual scores of the 
CT: 7% reticular pattern, 3% honeycombing, no ground glass opacity and 24% emphysema (i). CALIPER 
characterized 5% reticular pattern, 1% honeycombing, 2% ground glass opacity, 43% Grade 1, 10% 
Grade 2 and 4% Grade 3 decreased attenuation and 3% pulmonary vessel volume (PVV). A large 
proportion of the areas with interspaced patches of centrilobular emphysema were characterized as 
Grade I decreased attenuation by CALIPER as demonstrated on overlaid axial ii) and 3D rendered 
images (iii) but characterized as predominantly normal lung with only minor emphysema on visual 
scores.  
2B(i-iii) 48-year-old female never-smoker. Mean visual scores of the CT: 34% reticular pattern, 0.5% 
honeycombing, 45% ground glass opacity with no emphysema (i). CALIPER characterized 6% reticular 
pattern, 1% honeycombing, 62% ground glass opacity, no Grade 2 and 3 decreased attenuation and 
8% PVV. A large proportion of the areas visually labeled reticular pattern were characterized as 
ground glass opacity by CALIPER as demonstrated on overlaid axial (ii) and 3D rendered images (iii) 
reflecting a pattern of textured ground glass opacity that is often difficult to classify.  
2C(i-iii) 76-year-old male ex-smoker with a 20-pack year smoking history. Mean visual scores of the 
CT: 14% reticular pattern, 49% honeycombing, 5% ground glass opacity with no emphysema (i). 
CALIPER characterized 16% reticular pattern, 2% honeycombing, 24% ground glass opacity, 0·5% 
Grade 2 and 3 decreased attenuation and 9% PVV. A substantial proportion of the areas visually 
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labeled honeycombing were characterized as reticular pattern and/or ground glass opacity by 
CALIPER as shown on overlaid axial (ii) and 3D rendered images (iii).  
 
Figure 3. A 75-year-old ex-smoker diagnosed with idiopathic pulmonary fibrosis. Axial CT slice with 
CALIPER-derived colour overlay demonstrating intraparenchymal pulmonary arteries and veins (red). 
During the initial extraction process separating the lungs from the mediastinum and chest wall, the 
hilar structures including the central pulmonary arteries and veins were removed. Pulmonary vessels 
are classified by CALIPER using structure and textural analysis and computer vision-based image 
understanding of volumetric histogram signature mapping features for 9x9x9 voxel volume units. The 
pulmonary vessel volume is calculated by dividing the total lung vessel volume by the total lung 
volume and multiplying by 100. The caliber of vessels in the spared right lung are increased when 
compared to vessels within areas of fibrosis. 
 
Figure 4. Graph demonstrating the relationship between CPI derived from correlations between 
pulmonary function tests and ILD extent scored visually in a separate, historic cohort of IPF patients, 
and the CPI calculated using a new formula derived from correlations between pulmonary function 
tests and ILD extent scored by CALIPER in the current cohort (R2=0·95).  
 
Table 1. Patient age, gender and mean and standard deviations of pulmonary function tests, CALIPER 
and visually scored CT parameters and echocardiography data. Data represent mean values with 
standard deviations. CT = computed tomography, FEV1 = forced expiratory volume in one second, FVC 
= forced vital capacity, DLco = diffusing capacity for carbon monoxide, Kco = carbon monoxide 
transfer coefficient, TLC = total lung capacity, CPI = composite physiological index, ILD = interstitial 
lung disease, RVSP = right ventricular systolic pressure, TxBx = traction bronchiectasis. 
 
Table 2. Single determination standard deviation values of visual CT scores for idiopathic pulmonary 
fibrosis cases. CT = computed tomography. 
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Table 3. Univariate linear regression demonstrating relationships between disease in three 
compartments characterized by visual and CALIPER-derived scores and pulmonary function tests. 
CT=Computed tomography, ILD=interstitial lung disease, FEV1=forced expiratory volume in one 
second, FVC=forced vital capacity, DLco=diffusing capacity for carbon monoxide, Kco = carbon 
monoxide transfer coefficient, CPI=composite physiological index, NS=not significant.  
 
Table 4. Multivariate linear regression demonstrating relationships significant to a level of 0·01 between 
parenchymal patterns characterized by both visual and CALIPER scores with pulmonary function tests. 
Model 1 contained CALIPER ILD extent but excluded PVV. Model 2 contained PVV but excluded CALIPER ILD 
extent. CT= Computed tomography, FEV1=forced expiratory volume in one second, FVC=forced vital 
capacity, DLco=diffusing capacity for carbon monoxide, CPI=composite physiological index, ILD=interstitial 
lung disease, PVV= pulmonary vessel volume. 
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Variable (n = 283 unless stated) 
Units are percentage unless stated 
 Value 
 
Median Age (years)       67 
Male/female (ratio)    219/64  
FEV1 % predicted (n=257)  70·8 ± 19·1 
FVC % predicted (n=257)  68·8 ± 20·5 
DLco % predicted (n=254)  36·1 ± 12·9 
Kco % predicted (n=254)  69·0 ± 19·2 
CPI (n=249)  55·1 ± 11·7 
Echocardiography RVSP (mmHg) (n=150)  45·1 ± 16·8 
CALIPER ILD extent   26·5 ± 18·1 
  CALIPER Ground glass opacity   17·0 ± 14·7 
  CALIPER Reticular pattern     8·5 ± 6·0 
  CALIPER Honeycombing     1·0 ± 1·7 
CALIPER Grade 1 decreased attenuation   20·8 ± 20·7 
CALIPER Grade 2 decreased attenuation    0·8 ± 2·6 
CALIPER Grade 3 decreased attenuation    0·5 ± 2·8 
CALIPER pulmonary vessel volume    5·1 ± 1·7 
Visual ILD extent  43·1 ± 17·8 
  Visual Ground glass opacity   10·4 ± 11·4 
  Visual Reticular pattern   21·7 ± 10·9 
  Visual Honeycombing     9·8 ± 12·6 
  Visual Consolidation    1·1 ± 3·3 
Visual Emphysema     4·7 ± 10·9 
Visual TxBx severity (max score 18)    7·0 ± 3·3 
Main pulmonary artery diameter (mm)  30·3 ± 4·8 
Ascending aorta diameter (mm)  34·8 ± 4·2 
 
Table 1
Visual CT Variable (n = 283) 
 
 Single determination 
standard deviation 
CT Interstitial lung disease extent  7·24 
CT Ground glass opacity   6·15 
CT Reticular pattern   5·24 
CT Honeycombing   7·88 
CT Consolidation  2·69 
CT Total emphysema   4·99 
CT Mosaic attenuation   3·83 
CT Traction bronchiectasis severity  1·43 
 
Table 2
  CT Variable FEV1 FVC DLco Kco CPI  
 
ILD Visual 0.19, <0.0001  0.27, <0.0001 0.35, <0.0001 0.07, <0.0001 0.44, <0.0001 
CALIPER 0.29, <0.0001 0.41, <0.0001  0.31, <0.0001 NS 0.48, <0.0001 
Emphysema Visual NS 0.13, <0.0001 0.05, <0.0001 0.26, <0.0001 NS 
CALIPER NS 0.06, <0.0001 NS 0.08, <0.0001 0.03,   0.004 
Vessels Visual NS NS 0.03,   0.008 0.04,   0.001 NS 
 CALIPER 0.31, <0.0001 0.45, <0.0001 0.34, <0.0001 NS 0.53, <0.0001 
 
Table 3
 Pulmonary 
function 
test 
CT Pattern  Beta 
Coefficient 
95% 
Confidence 
Interval 
P value Model R2 
Model 1 FEV1 CALIPER Emphysema -0·98 -1·49, -0·46   0·0003 0·33 
CALIPER ILD extent -0·59 -0·70, -0·48 <0·0001 
 Visual Emphysema 0.33  0.09,   0.57   0.008  
FVC CALIPER ILD extent -0·67 -0·78, -0·56 <0·0001 0·46 
 Visual Emphysema  0·40  0·23,   0·57 <0·0001 
DLco CALIPER ILD extent -0·29 -0·38, -0·20 <0·0001 0·51 
 Visual Emphysema -0·40 -0·50, -0·29 <0·0001 
 Visual ILD extent -0·27 -0·36, -0·18 <0·0001 
CPI CALIPER ILD extent  0·32  0·24,   0·40 <0·0001 0·53 
 Visual ILD extent  0·21  0·14,   0·29 <0·0001 
Model 2  FEV1 CALIPER Emphysema -0·63 -1·01, -0·25   0·001 0·34 
CALIPER PVV -6·83 -8·02, -5·65 <0·0001 
FVC CALIPER PVV -7·56 -8·68, -6·43 <0·0001 0.48 
 Visual Emphysema  0·33  0·17,   0·50   0·0001 
DLco CALIPER PVV -3·81 -4·81, -2·80 <0·0001 0·53 
 Visual Emphysema -0·43 -0·54, -0·33 <0·0001 
 Visual ILD extent -0·22 -0·31, -0·13 <0·0001 
CPI CALIPER PVV  3·88  3.03,   4·74 <0·0001 0·56 
 Visual ILD extent  0·18  0·10,   0·25 <0·0001 
 
Table 4
  
Supplemental Appendix
Click here to access/download
Supplemental Data File (.doc, .tif, pdf, etc.)
Supplementary appendices.docx
